Clinical decision-making and secondary findings in systems medicine Donna Dickenson, Sandra Soo-Jin Lee, and Michael Morrison

BMC Medical Ethics

Volumn 17, Issue 1, 2016, Pages

  Fischer, T ^a   Brothers, K B ^b   Erdmann, P ^c   Langanke, M ^a,c  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Big data; Clinical decision making; Electronic health records; Epistemology; Scoring systems; Secondary findings; Systems medicine; Translation

Indexed keywords

ATTENTION; CLINICAL DECISION MAKING; CLINICAL MEDICINE; CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; CONSENSUS DEVELOPMENT; DEATH; DOCTOR PATIENT RELATION; ELECTRONIC HEALTH RECORD; EPISTEMOLOGY; ERROR; EXPERIMENTAL MEDICINE; GENOMICS; HEALTH CARE PERSONNEL; HUMAN; IMAGING; INTENSIVE CARE; JOINT; MORTALITY; PREDICTION; QUANTITATIVE STUDY; SCORING SYSTEM; ALGORITHM; DECISION MAKING; ETHICS; INCIDENTAL FINDING; INFORMATION PROCESSING; KNOWLEDGE; MEDICAL ETHICS; MEDICAL INFORMATICS; PERSONALIZED MEDICINE; PROGNOSIS; STATISTICS; SYSTEM ANALYSIS; SYSTEMS BIOLOGY; TRANSLATIONAL RESEARCH;

ALGORITHMS; CLINICAL DECISION-MAKING; DATA COLLECTION; DECISION MAKING; ETHICS, MEDICAL; HUMANS; INCIDENTAL FINDINGS; KNOWLEDGE; MEDICAL INFORMATICS; PHYSICIAN-PATIENT RELATIONS; PRECISION MEDICINE; PROGNOSIS; STATISTICS AS TOPIC; SYSTEMS ANALYSIS; SYSTEMS BIOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84969581348     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/s12910-016-0113-5     Document Type: Review

References (53)

1. Capobianco E. Ten challenges for systems medicine. Front Genet. 2012;3:193.
2. Capobianco E. Dynamic networks in systems medicine. Front Genet. 2013;3:185.
3. Hood L. Systems biology and P4 Medicine: Past, Present, and Future. RMMJ. 2013;4:e0012.
4. Price ND, Edelman LB, Lee I, Yoo H, Hwang D, Carlson G, et al. Systems Biology and Systems Medicine. In: Ginsburg J, Willard H, editors. Genomic and Personalized Medicine. London: Elsevier; 2013. p. 60-72.
5. Wolkenhauer O, Auffray C, Jaster R, Steinhoff G, Dammann O. The road from systems biology to systems medicine. Pediatr Res. 2013;73:502-7.
6. Schmutzler R, Huster S, Wasem J, Dabrock P. Risikoprädiktion: Vom Umgang mit dem Krankheitsrisiko. Dtsch Arztebl. 2015;112:A-910/B-762/C-738.
7. Langanke M, Lieb W, Erdmann P, Dörr M, Fischer T, Kroemer H, et al. The Meaning of "Individualized Medicine": A Terminological Adjustment of a Perplexing Term. In: Fischer T, Langanke M, Marschall P, Michl S, editors. Individualized medicine, ethical, economical and historical perspectives. Cham Heidelberg New York Dordrecht London: Springer; 2015. p. 11-28.
8. Schleidgen S, Klingler C, Bertram T, et al. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics. 2013;14:55.
9. Zhao Z, Shen B, Lu X, Vongsangnak W. Translational biomedical informatics and computational systems medicine. Biomed Res Int. 2013;2013:237465.
10. Sarkar IN. Biomedical informatics and translational medicine. J Transl Med. 2010;8:22.
11. Krüger-Brand HE. 2014. Forschungsinfrastrukturen: Herausforderungen durch Big Data. Dtsch Arztebl. 2015;111:A-1735/B-1497/C-1429.
12. Erdmann P, Fischer T, Raths S, Flessa S, Langanke M. Systemmedizin: Herausforderungen eines aktuellen Ansatzes. Dtsch Arztebl. 2015;112:A-1330/B-1116/C-1091.
13. Gomez-Cabrero D, Menche J, Cano I, Abugessaisa I, Huertas-Migueláñez M, Tenyi A, et al. Systems Medicine: from molecular features and models to the clinic in COPD. J Transl Med. 2014;12 Suppl 2:S4.
14. Mayer-Schönberger V, Cukier K. Big Data: A Revolution That Will Transform How We Live, Work, and Think. Boston: Houghton Mifflin Harcourt; 2013.
15. Flores M, Glusman G, Brogaard K, Price ND, Hood L. P4 medicine: how systems medicine will transform the healthcare sector and society. Pers Med. 2013;10(6):565-76.
16. Binder H, Blettner M. Big Data in der wissenschaftlichen Medizin - eine biostatistische Perspektive: Teil 21 der Serie zur Bewertung wissenschaftlicher Publikationen. Dtsch Arztebl Int. 2015;112:137-42.
17. Mainzer K. Algorithms are powerful and useful. But by themselves they are blind. Faszination Forschung. 2014;15:64-75.
18. Khoury MJ, Ioannidis JP. Big Data Meets Public Health. Science (New York, NY). 2014;346(6213):1054-5.
19. MacArthur D. Genome-wide association studies: failure or success? 2009. http://www.wired.com/2009/04/genome-wide-association-studies-failure-or-success/. Accessed 7 May 2015.
20. Roden DM, Pulley JM, Basford MA, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther. 2008;84(3):362-9.
21. Brothers KB. The Genome on the Horizon: Practical Reasoning in the Age of Personalized Medicine. 2015. http://etd.library.vanderbilt.edu/available/etd-03232015-115000/unrestricted/Brothers.pdf. (Accessed 17 May 2016).
22. Mao L, Jian C, Changzhi L, et al. Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Arch Cardiovasc Dis. 2013;106(10):517-27.
23. Trenk D, Hochholzer W. Genetics of platelet inhibitor treatment. Br J Clin Pharmacol. 2014;77(4):642-53.
24. Osnabrugge RL, Head SJ, Zijlstra F, et al. A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users. Genet Med. 2015;17(1):3-11.
25. Hodges A. Alan Turing: The Enigma. Princeton, N.J.: Princeton University Press; 2014.
26. Turing AM. Computing machinery and intelligence. Mind. 1950;59:433-60.
27. Knaus WA, Harrell Jr FE, Lynn J, Goldman L, Phillips RS, Connors Jr AF, et al. The SUPPORT Prognostic Model. Objective Estimates of Survival for Seriously Ill Hospitalized Adults. Ann Intern Med. 1995;122:191-203.
28. Moreno R, Afonso S. Ethical, legal and organizational issues in the ICU: prediction of outcome. Curr Opin Crit Care. 2006;12:619-23.
29. Schuster HP. Die Bedeutung von Score-Systemen für die Voraussage von Behandlungsergebnissen in der Intensivmedizin. Internist. 1996;37:1237-43.
30. Murdoch IA, Bihari DJ. Predictions in the intensive care unit - in search of an "unholy grail"! Pediatr Nephrol. 1993;7:708-10.
31. Lefering R, Wolfrum B, Wauer H, Neugebauer EA. Limitations of score-based daily outcome predictions in the individual intensive care patient. An example of the RIAHDH algorithm. Inflamm Res. 2004;53 Suppl 2:169-74.
32. Chang RW, Jacobs S, Lee B. Predicting outcome among intensive care unit patients using computerized trend analysis of daily Apache II scores corrected for organ system failure. Intensive Care Med. 1988;14:558-66.
33. Chang RW. Individual outcome prediction models for intensive care units. Lancet. 1989;2:143-6.
34. Chang RW, Bihari DJ. Outcome prediction for the individual patient in the ICU. Unfallchirurg. 1994;97:199-204.
35. Weber R, Vogt-Weber B. Computerprognose - Ärztliche Entscheidungen zwischen Statistik und Intuition. Juristische Aspekte von Prognose und Behandlungspflicht. MedR. 1999;5:204-9.
36. Zylka-Menhorn V."Todescomputer": Risikobewertung von Intensivpatienten. Dtsch Arztebl. 1997;94:A-621/B-523/C-499.
37. Jacobs S, Arnold A, Clyburn PA, Willis BA. The Riyadh Intensive Care Program applied to a mortality analysis of a teaching hospital intensive care unit. Anaesthesia. 1992;47:775-80.
38. Grundmann RT. Prognostizierbarkeit des Todes - Ärztliche Beurteilung oder Scores? In: Junginger T, Perneczky A, Vahl C-F, Werner C, editors. Grenzsituationen in der Intensivmedizin. Berlin Heidelberg: Springer; 2008. p. 153-63.
39. Downar J. Even without our biases, the outlook for prognostication is grim. Crit Care. 2009;13:168.
40. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268:2420-5.
41. Chang RW, Bihari DJ. The Riyadh Intensive Care Programme. Anaesthesia. 1993;48(4):345-6.
42. Erdmann P. Zufallsbefunde aus bildgebenden Verfahren in populationsbasierter Forschung. Münster: mentis; 2015.
43. Erdmann P. Handling Incidental Findings from Imaging within IM related Research - Results from an Empirical-Ethical Study. In: Fischer T, Langanke M, Marschall P, Michl S, editors. Individualized medicine, ethical, economical and historical perspectives. Cham Heidelberg New York Dordrecht London: Springer; 2015. p. 231-50.
44. Rudnik-Schöneborn S, Langanke M, Erdmann P, Robienski J. Ethische und rechtliche Aspekte im Umgang mit genetischen Zufallsbefunden - Herausforderungen und Lösungsansätze. Ethik Med. 2014;26:105-19.
45. Langanke M, Erdmann P, Robienski J, Rudnik-Schöneborn S, editors. Zufallsbefunde bei molekulargenetischen Untersuchungen. Medizinische, juristische und ethische Perspektiven. Heidelberg Berlin: Springer-Verlag; 2015.
46. Schmidt CO, Hegenscheid K, Erdmann P, Kohlmann T, Langanke M, Völzke H, et al. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study. Eur Radiol. 2013;23:1343-51.
47. Brothers KB, Langanke M, Erdmann P. Implications of the incidentalome for clinical pharmacogenomics. Pharmacogenomics. 2013;14:1353-62.
48. Heinemann T, Hoppe C, Listl S, Spickhoff A, Elger CE. Zufallsbefunde bei bildgebenden Verfahren in der Hirnforschung. Ethische Überlegungen und Lösungsvorschläge. Dtsch Arztebl. 2007;104:A-1982/B-1748/C-1684.
49. Grabe H, Assel H, Bahls T, Dörr M, Endlich K, Endlich N, et al. Cohort profile: Greifswald approach to individualized medicine (GANI-MED). J Transl Med. 2014;12:144.
50. Fischer T, Langanke M, Marschall P, Michl S, editors. Individualized medicine, ethical, economical and historical perspectives. Cham Heidelberg New York Dordrecht London: Springer; 2015.
51. Fischer T, Dörr M, Haring R, Langanke M. Alarming symptoms of a paradigm shift? An approach to bridge the gap between hypothetical ethics and the current status of IM research. In: Vollmann J, Schildmann J, editors. Personalised Medicine: Ethical, Medical, Economic and Legal Critical Perspectives. Fulham: Ashgate Publishing Limited; 2015. p. 25-40.
52. Dabrock P. Public Health Genetics and Social Justice. Community Genet. 2006;9:34-9.
53. Mittelstadt BD, Luciano F. The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts. Sci Eng Ethics. 2015;29:1-39.